Convertible Agreement Regarding Equity Template for Malaysia

A Convertible Agreement Regarding Equity (CARE) is a sophisticated financing instrument that provides a flexible solution for Malaysian companies seeking investment capital without immediate share price determination. This agreement allows investors to contribute funds with the right to convert their investment into company shares at a future date, typically triggered by specific events or milestones. You'll find this document particularly valuable when navigating Malaysia's dynamic startup landscape where traditional equity valuations may be challenging or premature.

When do you need this document?

You'll require a CARE when your company is in early-stage development and traditional equity valuation proves difficult due to limited operating history or uncertain market conditions. This document becomes essential during seed funding rounds, bridge financing arrangements, or when attracting strategic investors who prefer conversion flexibility. Malaysian tech startups, biotech companies, and innovative businesses often utilize CAREs to secure capital while postponing complex valuation discussions until achieving significant milestones such as product launches, revenue targets, or subsequent funding rounds.

Key legal considerations

Your CARE must clearly define conversion triggers, which typically include qualified financing events, company sale scenarios, or predetermined maturity dates. The conversion price mechanism requires careful structuring, often incorporating valuation caps, discount rates, or most-favoured-nation provisions to protect investor interests. You should address investor rights during the conversion period, including information rights, board representation potential, and anti-dilution protections. The agreement must specify conditions precedent for the investment, such as due diligence completion, regulatory approvals, and shareholder consents. Consider including provisions for automatic conversion scenarios, voluntary conversion rights, and treatment of accrued interest or dividends.

Legal requirements in Malaysia

Under the Companies Act 2016, your company must ensure proper authorization for issuing convertible instruments through board resolutions and, where necessary, shareholder approvals. The Capital Markets and Services Act 2007 may apply if your CARE constitutes a security requiring Securities Commission oversight, particularly for public solicitation or substantial investor numbers. You must comply with foreign investment regulations under the Financial Services Act 2013 if involving overseas investors, potentially requiring Bank Negara Malaysia approvals. The agreement should address Malaysian tax implications under the Income Tax Act 1967, including stamp duty obligations and potential withholding tax on conversion events. Ensure compliance with Securities Commission Guidelines on Unlisted Capital Market Products if applicable, and consider Malaysian Anti-Money Laundering and Anti-Terrorism Financing requirements for investor verification and reporting obligations.